Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crawford on RFID

This article was originally published in The Tan Sheet

Executive Summary

An FDA guidance expected by mid-year on radio frequency identification for drug packaging will more strongly recommend use of the technology, Acting Commissioner Lester Crawford said at a Pharmaceutical Education Associates Fraud & Abuse Conference March 22. RFID implementation in the U.S. has fallen behind Europe, Crawford maintained at the meeting. FDA, which issued the original RFID guidance in November 2004, anticipates the technology will be widely used by 2007. OTC drugs may be last to carry RFID due to the high cost of the tags...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098003

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel